Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1993-9-16
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0891-6934
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
14
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
343
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8347777-Autoimmune Diseases,
pubmed-meshheading:8347777-Genes, MHC Class II,
pubmed-meshheading:8347777-HLA-DR Antigens,
pubmed-meshheading:8347777-HLA-DRB1 Chains,
pubmed-meshheading:8347777-Histocompatibility Antigens Class II,
pubmed-meshheading:8347777-Humans,
pubmed-meshheading:8347777-Insulin,
pubmed-meshheading:8347777-Syndrome
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Insulin autoimmune syndrome; HLA genes may be a marker of disease heterogeneity.
|
| pubmed:publicationType |
Letter
|